PTC Therapeutics, Inc. (PTCT)
71.06
+1.24
(+1.78%)
USD |
NASDAQ |
Aug 24, 16:00
71.02
-0.04
(-0.06%)
After-Hours: 20:00
PTC Therapeutics Shareholders Equity (Quarterly) : -165.36M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -165.36M |
| March 31, 2026 | -180.46M |
| December 31, 2025 | -205.31M |
| September 30, 2025 | -155.76M |
| June 30, 2025 | -206.55M |
| March 31, 2025 | -185.76M |
| December 31, 2024 | -1.098B |
| September 30, 2024 | -1.054B |
| June 30, 2024 | -980.18M |
| March 31, 2024 | -893.92M |
| December 31, 2023 | -818.56M |
| September 30, 2023 | -670.81M |
| June 30, 2023 | -579.27M |
| March 31, 2023 | -457.56M |
| December 31, 2022 | -347.09M |
| September 30, 2022 | -226.90M |
| June 30, 2022 | -182.22M |
| March 31, 2022 | -90.58M |
| December 31, 2021 | 1.438M |
| September 30, 2021 | 104.93M |
| June 30, 2021 | 196.58M |
| March 31, 2021 | 292.58M |
| December 31, 2020 | 481.98M |
| September 30, 2020 | 510.95M |
| June 30, 2020 | 572.49M |
| Date | Value |
|---|---|
| March 31, 2020 | 528.73M |
| December 31, 2019 | 594.33M |
| September 30, 2019 | 663.65M |
| June 30, 2019 | 488.68M |
| March 31, 2019 | 512.94M |
| December 31, 2018 | 350.73M |
| September 30, 2018 | 386.09M |
| June 30, 2018 | 267.40M |
| March 31, 2018 | 150.31M |
| December 31, 2017 | 156.44M |
| September 30, 2017 | 145.88M |
| June 30, 2017 | 169.73M |
| March 31, 2017 | 100.83M |
| December 31, 2016 | 119.58M |
| September 30, 2016 | 140.18M |
| June 30, 2016 | 165.62M |
| March 31, 2016 | 196.00M |
| December 31, 2015 | 226.00M |
| September 30, 2015 | 269.15M |
| June 30, 2015 | 248.58M |
| March 31, 2015 | 273.32M |
| December 31, 2014 | 298.47M |
| September 30, 2014 | 201.30M |
| June 30, 2014 | 223.76M |
| March 31, 2014 | 244.34M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Insmed, Inc. | 757.49M |
| Madrigal Pharmaceuticals, Inc. | 523.72M |
| Protagonist Therapeutics, Inc. | 841.54M |
| Biogen, Inc. | 18.85B |
| BioMarin Pharmaceutical, Inc. | 6.322B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.250B |
| Total Liabilities (Quarterly) | 3.416B |
| Debt to Equity Ratio | -4.212 |
| Current Ratio | 3.394 |
| Net Debt Paydown Yield | -0.90% |